Actively Recruiting
Transcutaneous Electrical Acupoint Stimulation for Postoperative Urinary Retention After Radical Surgery for Cervical Cancer
Led by Lu Chao · Updated on 2026-02-06
76
Participants Needed
1
Research Sites
158 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a prospective, blinded, single-center, randomized controlled trial. We will include 76 patients with postoperative urinary retention (POUR) after radical hysterectomy for cervical cancer who have a clear diagnosis and meet the screening criteria as the research object. They will be randomly divided into the transcutaneous electrical acupoint stimulation（TEAS）group and the sham TEAS group according to a 1:1 ratio. Each group consists of 38 patients, and all patients will be required to sign a written informed consent form. The TEAS group will be treated with TEAS based on conventional treatment, and the sham TEAS group will be treated with shamTEAS based on conventional treatment. The main outcomes will be the changes in post-void residual (PVR) volume; secondary indicators will include the response rate of participants with successful urinary catheter removal after intervention, assessment of urinary tract infection (UTI), and patient quality of life assessment according to the EORTC QLQ-C30 scale. The participants will also be evaluated with expectations, blind evaluation, compliance evaluation, and safety evaluation to preliminarily evaluate the effect of TEAS for postoperative urinary retention after radical hysterectomy for cervical cancer.
CONDITIONS
Official Title
Transcutaneous Electrical Acupoint Stimulation for Postoperative Urinary Retention After Radical Surgery for Cervical Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 18 and 70 years with an expected survival period of at least 6 months
- Diagnosed with postoperative urinary retention and having an indwelling catheter for more than 14 days but less than 1 year
- No history of urinary system diseases before surgery
- Clear consciousness, able to communicate and learn TEAS operation
- No serious systemic diseases such as heart, liver, brain, or kidney conditions
- Karnofsky functional status score (KPS) of 70 points or higher
- Willing to participate and able to sign written informed consent
You will not qualify if you...
- Obstructive urinary retention like urethral stricture or stones
- Serious systemic diseases or advanced cachexia
- Presence of pacemaker or metal implants in the body
- Skin lesions or conditions unsuitable for TEAS treatment at the treatment site
- Physical or mental disorders causing cognitive impairment
- Currently participating in other clinical trials affecting study results
- Unwillingness to participate in clinical trials
- Determined by evaluator as unsuitable for participation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Zhejiang Cancer Hospital
Hangzhou, Zhejiang, China, 310022
Actively Recruiting
Research Team
C
Chao Lu
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here